BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 7598715)

  • 21. Antiestrogens are partial estrogen agonists for prolactin production in primary pituitary cultures.
    Martinez-Campos A; Amara JF; Dannies PS
    Mol Cell Endocrinol; 1986 Dec; 48(2-3):127-33. PubMed ID: 3803705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catecholamines modulate growth and differentiation of human preosteoclastic cells.
    Frediani U; Becherini L; Lasagni L; Tanini A; Brandi ML
    Osteoporos Int; 1996; 6(1):14-21. PubMed ID: 8845594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between ipriflavone and the estrogen receptor.
    Petilli M; Fiorelli G; Benvenuti S; Frediani U; Gori F; Brandi ML
    Calcif Tissue Int; 1995 Feb; 56(2):160-5. PubMed ID: 7736326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skeletal effects of estrogens.
    Fiorelli G; Brandi ML
    J Endocrinol Invest; 1999 Sep; 22(8):589-93. PubMed ID: 10532245
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytokines in the pathogenesis of osteoporosis.
    Romas E; Martin TJ
    Osteoporos Int; 1997; 7 Suppl 3():S47-53. PubMed ID: 9536302
    [No Abstract]   [Full Text] [Related]  

  • 26. Heterogeneity of binding sites and bioeffects of raloxifene on the human leukemic cell line FLG 29.1.
    Fiorelli G; Martineti V; Gori F; Benvenuti S; Frediani U; Formigli L; Zecchi S; Brandi ML
    Biochem Biophys Res Commun; 1997 Nov; 240(3):573-9. PubMed ID: 9398606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding and bioeffects of Ipriflavone on a human preosteoclastic cell line.
    Benvenuti S; Petilli M; Frediani U; Tanini A; Fiorelli G; Bianchi S; Bernabei PA; Albanese C; Brandi ML
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1084-9. PubMed ID: 7517664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estradiol and raloxifene decrease the formation of multinucleate cells in human bone marrow cultures.
    Ramalho AC; Couttet P; Baudoin C; Morieux C; Graulet AM; de Vernejoul MC; Cohen-Solal ME
    Eur Cytokine Netw; 2002; 13(1):39-45. PubMed ID: 11956019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The antiestrogen LY117018 is estrogenic in the fetal rat.
    Henry EC; Miller RK
    Teratology; 1986 Aug; 34(1):59-63. PubMed ID: 3764778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro.
    Hall TJ; Nyugen H; Schaueblin M; Fournier B
    Biochem Biophys Res Commun; 1995 Nov; 216(2):662-8. PubMed ID: 7488162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M
    APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for bioeffects of LY 139478 on the human pre-osteoclastic cell line FLG 29.1.
    Fiorelli G; Gori F; Frediani U; Morelli AM; Falchetti A; Benvenuti S; Masi L; Brandi ML
    Biochem Biophys Res Commun; 1995 Jun; 211(3):857-63. PubMed ID: 7598715
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.